Another week with continued selling.... This is a sellers stock as people who once believed they could get something done, know at this point it is a long shot at best. Even if they somehow get money to finance the drug trials it will be a year for results, then they have to get the product to market... So a year and half before any real value...
News 
Market Data 
Discover 
